In vitro interactions between γδT cells, DC, and CD4 + T cells; implications for the immunotherapy of leukemia

References

• Raulet DH. The structure, function, and molecular genetics of the 7/6 T cell receptor. Annu Rev Immunol 1989;7:175–207.
   PubMed Web of Science ®Google Scholar
• Bigby M, Markowitz JM, Bleicher PA et al. Most yö T cellsdevelop normally in the absence of MHC class II antigens. y Immund 1993;151:4465–75.
   PubMed Web of Science ®Google Scholar
• Lanier L. Unusual lymphocytes — yö T cells and NK cells. Immunologist 1995;3:182–4.
   Google Scholar
• Schild H, Mavaddat N, Litzenberger C et al. The nature of major histocompatibility complex recognition by yö+ T cells. Cell 1994;76:29–37.
   PubMed Web of Science ®Google Scholar
• Sperling AI, Linsley PS, Barrett TA, Bluestone JA. CD28-mediated costimulation is necessary for the activation of T cell receptor-7ö + T lymphocytes. y Immunol 1993;151: 6043–50.
   Google Scholar
• Wesselborg 5, Janssen 0, Pechhold K, Kabelitz D. Selective activation of VS+ T cells by single anti-CD2 antibodies. Exp Med 1991;173: 297–304.
   Google Scholar
• Ensslin AS, Formby B. Comparison of cytolytic and prolif-erative activities of human yö and c43 T cells from peripheral blood against various human tumor cell lines. y Natl Cancer Inst 1991;83:1569–9.
   PubMedGoogle Scholar
• Hacker G, Kromer S, Falk Metal. VS 1 subset of human yö T cells responds to ligands expressed by EBV-infected Burkitt lymphoma cells and transformed B lymphocytes. Immunol1992;149: 3989–9.
   Google Scholar
• Marx S, Wesch D, Kabelitz D. Activation of human yö T cells by Mycobacterium tuberculosis and Daudi lymphoma cells. y Immunol 1997;158:2842–8.
   Google Scholar
• Schilbach KE, Geiselhart A, Wessels JT et al. Human yö T lymphocytes exert natural and IL-2-induced cytotoxicity to neuroblastoma cells. y Immunother 2000;23:536–48.
   PubMed Web of Science ®Google Scholar
• Fisch P, Malkovsky M, Braakman E et al. Gamma/delta T cell clones and natural killer cell clones mediate distinct patterns of non-major histocompatibility-restricted cytoly-sis. yExp Med 1990;171:1567–79.
   PubMed Web of Science ®Google Scholar
• Kaur I, Voss SD, Gupta RS et al. Human peripheral gamma/delta T cells recognize hsp60 molecules on Daudi Burkitt's lymphoma cells. y Immunol 1993;150:2046–55.
   Google Scholar
• Battistini L, Salvetti M, Ristori G et al. Gamma delta T cell receptor analysis supports a role for HSP 70 selection of lymphocytes in multiple sclerosis lesions. Mol Med 1995;1:559–62.
   Web of Science ®Google Scholar
• Lamb LS Jr, Henslee-Downey PJ, Parrish RS et al. Increased frequency of TCR-7ö+ T cells in disease-free survivors fol-lowing T cell-depleted partially mismatched, related donor bone marrow transplantation for leukemia. .7 Hematother 1996;5:503–9.
   PubMedGoogle Scholar
• Lamb LS, Hazlett L, Musk P et al. Influence of T cell deple-tion method on circulating yö+ T cell reconstitution and potential role in the graft-versus-leukemia effect. Cytotherapy 1999;1:7–19.
   PubMed Web of Science ®Google Scholar
• Lamb LS Jr, Musk P, Ye Z et al. Human yö+ T lymphocytes have in vitro graft versus leukemia activity in the absence of an allogeneic response. Bone Marrow Transplant 2001;27:601–6.
   PubMed Web of Science ®Google Scholar
• Kjeldsen-Kragh J, Quayle AG, Skalhegg BS et al. Selective activation of resting human yö T lymphocytes by inter-leukin-2. Eur Immund1993;23:2092–9.
   PubMed Web of Science ®Google Scholar
• Yamaguchi T, Suzuki Y, Katakura R et al. Interleukin-15 effectively potentiates the in vitro tumor-specific activity and proliferation of peripheral blood yö T cells isolatedfrom glioblastoma patients. Cancer Immunol Immunother 1998;47:97–103.
   PubMed Web of Science ®Google Scholar
• Lopez RD, Xu S, Guo B et al. C D2-mediated IL-12-dependentsignals render human 76-T cells resistant to mitogen-induced apoptosis, permitting the large-scale ex vivo expansion of functionally distinct lymphocytes: implica-tions for the development of adoptive immunotherapy strategies. Blood 2000;96:3827–37.
   PubMed Web of Science ®Google Scholar
• Kunzmann V, Bauer E, Feurle J et al. Stimulation of 76 T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma. Blood 2000;96:389–92.
   Web of Science ®Google Scholar
• Hart DN. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 1997; 90:3245–87.
   PubMed Web of Science ®Google Scholar
• Young JW, Steinman RM. Dendritic cells stimulate primary human cytolytic lymphocyte responses in the absence ofCD4helper T cells. y Exp Med 1990;171:1315–32.
   PubMed Web of Science ®Google Scholar
• Takamizawa M, Fagnoni F, Mehta-Damani A et al. Cellular and molecular basis of human 76 T cell activation: role of accessory molecules in alloactivation. 7 Clin Invest 1995;95: 296–303.
   PubMed Web of Science ®Google Scholar
• Hanrahan CF, Kimpton WG, Howard CJ et al. Cellular requirements for the activation and proliferation of ruminant76 T cells. y Immunol 1997;159:4287–94.
   Google Scholar
• Ye Z, Gee AP, Bowers WE et al. In vitro expansion and charac-terization of dendritic cells derived from human bone marrow CD34+ cells. Bone Marrow Transplant 1996;18: 997–1008.
   PubMed Web of Science ®Google Scholar
• Beran M, Pisa P, O'Brien S et al. Biological properties and growth in SCID mice of a new myelogenous leukemia cell line (KBM-5) derived from chronic myelogenous leukemia cells in the blastic phase. Cancer Res 1993;53: 3603–10.
   Google Scholar
• Tsujimura K, Takahashi T, Morita A et al. Positive selection of 76 CTL by TL antigen expressed in the thymus. y Exp Med 1996;184:2175–84.
   PubMed Web of Science ®Google Scholar
• Okumura C, Suto R, Furukawa K et al. Induction of murine76 T cells cytotoxic for xenogeneic rat cells. y Immunol 1995;154:1119–23.
   Google Scholar
• Nakajima H, Tomiyama H, Takiguchi M. Inhibition of 76 T cell recognition by receptors for MHC class I molecules. Immunol 1995;155: 4139–42.
   Google Scholar
• Visonneau S, Cesano A, Santoli D. A revertant TCR76+ cell clone which has lost MHC nonrestricted cytotoxic activity but retains redirected killing upon stimulation of the CD3 receptor. Cell Immunol 1995;165: 252–65.
   Google Scholar
• Kawamura T, Kawachi Y, Moroda T et al. Cytotoxic activity against tumor cells mediated by intermediate TCR cells in the liver and spleen. Immunology 1996;89: 68–75.
   PubMed Web of Science ®Google Scholar
• Wallace M, Bartz SR, Chang WL et al. 76 lymphocyte responses to HIV. Clin Exp Immunol 1996;103:177–84.
   PubMed Web of Science ®Google Scholar
• Bukowski JF, Morita CT, Brenner MB. Recognition and destruction of virus-infected cells by human 76 CTL. Immunol 1994;153: 5133–40.
   Google Scholar
• Boismenu R, Havran WL. 76 T cells in host defense and epithelial cell biology. Clin Immunol Immunopathol 1998;86: 121–33.
   PubMedGoogle Scholar
• Choudhary A, Davodeau F, Moreau A et al. Selective lysis of autologous tumor cells by recurrent 76 tumor-infiltrating lymphocytes from renal carcinoma. y Immunol 1995;154: 3932–40.
   Google Scholar
• Duval M, Yotnda P, Bensussan A et al. Potential antileukemic effect of 76 T cells in acute lymphoblastic leukemia. Leukemia 1995;9:863–8.
   PubMed Web of Science ®Google Scholar
• Laad AD, Thomas ML, Fakih AR, Chiplunkar SV. Human gamma delta T cells recognize heat shock protein-60 on oral tumor cells. Int .7 Cancer 1999;80:709–14.
   PubMed Web of Science ®Google Scholar
• Yu Y, Hagihara M, Ando K et al. Enhancement of human cord blood CD34+ cell-derived NK cell cytotoxicity by dendritic cells. y Immunol 2001;166:1590–600.
   Google Scholar
• Ferlazzo G, Tsang M, Moretta L. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. y Exp Med 2002;195: 343–51.
   Google Scholar
• Giuntoli RL, Lu J, Kennedy R et al. Helper T-cells potenti-ate the effector function and growth of anti-tumor cytotoxic T lymphocytes. EASEB y 2001;15:A662.
   Google Scholar
• Spaner D, Cohen BL, Miller RG, Philips RA. Antigen-presenting cells for naive transgenic 76 T cells: potent activation by activated a43 T cells. y Immunol 1995;155: 3866–76.
   Google Scholar
• Mami-Chouaib E Del Porto P, Delorme D, Hercend T Further evidence for a 7/6 T cell receptor-mediated TCT.1/CD48 recognition. y Immunol 1991;147: 2869–7.
   Google Scholar
• Steinle A, Groh V, Spies T Diversification, expression, and gamma delta T cell recognition of evolutionarily distant members of the MIC family of major histocompatibility complex class I-related molecules. Proc Natl Acad Sci USA 1998;95:12510–5.
   PubMed Web of Science ®Google Scholar
• Norton J, Al-Saffar N, Sloane JP. An immunohistological study of 7/6 lymphocytes in human cutaneous graft-versus-host disease. Bone Marrow Transplant 1991;7:205–8.
   PubMed Web of Science ®Google Scholar
• Tsuji S, Char S, Bucy RP et al. 76 T cells are secondary par-ticipants in acute graft-versus-host interactions initiated by C D4 c43 T cells. Eur y Immunol 1 996;26:420–7.
   Google Scholar
• Blazar BR, Taylor PA, Bluestone JA, Vallera DA. Murine 7/6-expressing T cells affect alloengraftment via the recog-nition of nonclassical major histocompatibility complex class lb antigens. Blood 1996;87:4463–72.
   PubMed Web of Science ®Google Scholar